Pulmonary Rehabilitation and Quality of Life in Children With Chronic Lung Diseases: A Multidisciplinary Approach

NCT ID: NCT06870032

Last Updated: 2025-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

400 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-01

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic lung diseases (CLDs) such as asthma, cystic fibrosis, and bronchopulmonary dysplasia significantly impact pediatric patients' respiratory function and overall well-being. Pulmonary rehabilitation (PR) has been shown to improve lung function, exercise tolerance, and quality of life in affected individuals. However, limited research has been conducted on PR implementation in Egypt.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pulmonary rehabilitation significantly enhances respiratory function, exercise capacity, and quality of life in pediatric patients with CLDs while reducing healthcare utilization. These findings highlight the necessity of integrating structured PR programs into pediatric respiratory care in Egypt.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Lung Disease Quality of Life Respiratory Function Impaired

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

standard medical care group

Patients receiving standard medical care without structured pulmonary rehabilitation.

Group Type ACTIVE_COMPARATOR

standard medical care

Intervention Type OTHER

standard medical care

structured pulmonary rehabilitation

The experimental group underwent a 12-week structured pulmonary rehabilitation program.

Group Type OTHER

structured pulmonary rehabilitation

Intervention Type OTHER

structured pulmonary rehabilitation program including:

* Physical Therapy: Breathing exercises, airway clearance techniques, inspiratory muscle training.
* Pediatrics \& Chest Medicine: Medical supervision, optimization of pharmacological treatment.
* Physiology: Monitoring pulmonary function and physiological responses to exercise.
* Public Health: Evaluating program feasibility and its impact on healthcare utilization.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

structured pulmonary rehabilitation

structured pulmonary rehabilitation program including:

* Physical Therapy: Breathing exercises, airway clearance techniques, inspiratory muscle training.
* Pediatrics \& Chest Medicine: Medical supervision, optimization of pharmacological treatment.
* Physiology: Monitoring pulmonary function and physiological responses to exercise.
* Public Health: Evaluating program feasibility and its impact on healthcare utilization.

Intervention Type OTHER

standard medical care

standard medical care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosed cases of CLDs, stable clinical condition, and ability to participate in rehabilitation.

Exclusion Criteria

* Severe comorbidities, recent respiratory infections, or contraindications to physical activity.
Minimum Eligible Age

6 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Horus University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mohamed Salah El-Sayed

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mohamed El-Sayed

Role: PRINCIPAL_INVESTIGATOR

Horus University in Egypt

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Out-patient Clinic, Faculty of Physical Therapy, Horus University

Damietta, , Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PostDoc_012025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pulmonary Outcomes on Patients With Lung Fibrosis
NCT07088185 ACTIVE_NOT_RECRUITING NA